Fusion Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid
Fusion Pharmaceuticals Inc. had Lessee, Operating Lease, Liability, to be Paid of $24.05 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2024-05-07
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid $24.05M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $25.16M.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid $27.80M.
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid $27.05M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2024-03-31 | $24.05M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $25.16M 10-K · filed 2024-03-20 |
| 2023-09-30 | $27.80M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $27.05M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $26.82M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.73M 10-K · filed 2023-03-16 |
| 2022-09-30 | $7.08M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.54M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.96M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $7.64M 10-K · filed 2022-03-17 |
| 2021-09-30 | $8.11M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $8.44M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $8.70M 10-Q · filed 2021-05-11 |